Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vilazodone for Adult Separation Anxiety Disorder
NCT01999920Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Dec 2013
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vilazodone in separation anxiety disorder (SAD), sponsored by New York State Psychiatric Institute. Started Dec 2013; status: completed.
02
Drugs
vilazodone
03
Conditions
separation anxiety disorder (SAD)
Beyond the preview
Go deeper on NCT01999920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01999920.